R&D
When costing and compliance collide
Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
News
Grail plans FDA filing for cancer blood test after new trial
Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.
News
FDA blocks trials that send US cells to 'hostile' countries
The FDA says it will review clinical trials that send US citizens' cells to 'hostile countries' as the agency's leadership in this area is sidelined.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
R&D
Precision, speed, impact: Evolving mass spectrometry for med...
MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks